Sure do not appreciate you pumping something that is more than a year away from completing pivotal studies, when Seven Plus is on the market and collaborating with One Touch to close the loop. Go to the Echo board if you want to talk about that.
I'm not trying to offend you "freewilly", I'm just pointing out some interesting facts about the glucose monitoring space.
I do think that DXCM is a good company and will increase in value, I own it too. I'm simply pointing out that with a 30mil market cap there is more room for ECTE to increase in value as strategic partnerships are announced and as ECTE ramps up into 2010.
The space is very large and there is room for more than one "pony" in this race. If you like the potential of glucose monitoring, then it is worth doing some DD on other stocks like ECTE to spread your chips on the table.